GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Hile Bio-Technology Co Ltd (SHSE:603718) » Definitions » Gross-Profit-to-Asset %

Shanghai Hile Bio-Technology Co (SHSE:603718) Gross-Profit-to-Asset % : 7.45% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Hile Bio-Technology Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Shanghai Hile Bio-Technology Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥123.0 Mil. Shanghai Hile Bio-Technology Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥1,651.5 Mil. Therefore, Shanghai Hile Bio-Technology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 7.45%.


Shanghai Hile Bio-Technology Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Shanghai Hile Bio-Technology Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Hile Bio-Technology Co Gross-Profit-to-Asset % Chart

Shanghai Hile Bio-Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.50 6.96 10.67 10.54 7.80

Shanghai Hile Bio-Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.51 6.18 7.95 6.12 7.45

Competitive Comparison of Shanghai Hile Bio-Technology Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Shanghai Hile Bio-Technology Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Hile Bio-Technology Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Hile Bio-Technology Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Shanghai Hile Bio-Technology Co's Gross-Profit-to-Asset % falls into.



Shanghai Hile Bio-Technology Co Gross-Profit-to-Asset % Calculation

Shanghai Hile Bio-Technology Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=123.718/( (1514.253+1657.75)/ 2 )
=123.718/1586.0015
=7.80 %

Shanghai Hile Bio-Technology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=123.004/( (1657.75+1645.166)/ 2 )
=123.004/1651.458
=7.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Shanghai Hile Bio-Technology Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Shanghai Hile Bio-Technology Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Hile Bio-Technology Co (SHSE:603718) Business Description

Traded in Other Exchanges
N/A
Address
Shanghai Jinhai Road 6720, Shanghai, CHN, 201403
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
Executives
Zhang Lu Director
Liu Han Ping Directors, senior managers
Zhou Yu Sheng Supervisors
Zhang Hai Ming Director
Sun Guo Bao Supervisors
Zhang Yue Director
Su Bin Director
Wu Ling Yue senior management

Shanghai Hile Bio-Technology Co (SHSE:603718) Headlines

No Headlines